BROWARD HEALTH MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.9M
- Transactions
- 992
- Companies
- 40
- Average per transaction
- $2,960
Who reported the payments
| Gilead | $1,091,123 |
| Seagen Inc. | $427,131 |
| Pfizer | $247,448 |
| Karyopharm Therapeutics Inc. | $203,592 |
| Fujirebio Diagnostics, Incorporated | $195,188 |
| Abbott | $123,004 |
| Boston Scientific | $106,546 |
| Intuitive Surgical | $77,800 |
| Incyte Corporation | $75,053 |
| Medline Industries LP | $62,810 |
| AstraZeneca | $50,250 |
| AbbVie | $31,427 |
| Astrazeneca UK Limited | $30,609 |
| Stryker | $23,706 |
| Microport CRM USA Inc | $22,535 |
| Impulse Dynamics (USA) Inc. | $15,087 |
| Daiichi Sankyo Inc. | $13,841 |
| Novocure Inc. | $12,150 |
| Linvatec Corporation | $10,391 |
| Boehringer Ingelheim | $10,000 |
| Alnylam Pharmaceuticals Inc. | $10,000 |
| Biotronik Inc. | $8,959 |
| Viiv Healthcare Company | $8,233 |
| Olympus America Inc. | $7,840 |
| Zimmer Biomet | $6,736 |
| Medtronic | $6,000 |
| Biosense Webster, Inc. | $5,000 |
| Bridgebio Pharma, Inc. | $5,000 |
| Merck | $4,000 |
| Smith+Nephew | $3,846 |
| Penumbra, Inc. | $3,700 |
| Aesculap, Inc. | $3,546 |
| Nihon Kohden America, LLC | $3,000 |
| Siemens Medical Solutions USA, Inc. | $2,864 |
| Puma Biotechnology, Inc. | $2,800 |
| Novo Nordisk | $2,500 |
| Novartis | $2,500 |
| Edwards Lifesciences | $2,500 |
| Bayer | $2,500 |
| Johnson & Johnson | $2,200 |